In an 13D filing on K-V Pharmaceutical (NYSE: KV-a), AmediusTec Ltd. disclosed a 5% stake, or 2,636,345 shares.

This article: 115 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE